Clonally expanded CD8+ T cells appear to play a causal role in the initiation and progression of alopecia areata.

Ravi Vij, MD, MBA, explains how insurance-related delays in CAR T approval slow treatment initiation, increase interim therapy costs, and contribute to patient burden.

Treatment challenges that Anasuya Gunturi, MD, PhD, encounters in her work at Lowell General Hospital include language ...

“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...

Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like ...

Panelists discuss the anticipated 2026 updates to the American Academy of Dermatology guidelines for hidradenitis suppurativa ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...